» Articles » PMID: 23681114

Differential Expression of E-cadherin, β-catenin, and Lewis X Between Invasive Hydatidiform Moles and Post-molar Choriocarcinomas

Overview
Journal Virchows Arch
Date 2013 May 18
PMID 23681114
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Trophoblast cell adhesion and migration are carefully coordinated during normal placental development. We have compared the expression of three adhesion molecules, E-cadherin, β-catenin, and Lewis x, by immunohistochemistry during normal trophoblast differentiation, and in hydatidiform moles and choriocarcinomas. Both E-cadherin and β-catenin were expressed in normal placenta cytotrophoblast, and this expression decreased with trophoblast maturation. E-cadherin was mainly localized along the contact between cytotrophoblast and syncytiotrophoblast, which indicates its role in the differentiation of the syncytial layer. Lewis x disappeared progressively during differentiation of normal villous vessels, and was expressed in molar pregnancies. Interestingly, whereas choriocarcinomas were not, or poorly, stained, invasive hydatidiform moles (invHMs) strongly expressed Lewis x in vascular structures. This observation correlated well with E-cadherin and β-catenin expression and suggests that these three markers are associated with the invasive transformation. The presence of robust endothelial structures in invHMs could also explain their ability to maintain organized villous architecture (contrary to metastatic choriocarcinomas) during their invasion of extrauterine tissues such as the lung or the brain after dissemination through the blood flow. In our hands, Lewis x appeared to be a new, reliable marker that can be used to clearly distinguish invHMs from choriocarcinomas.

Citing Articles

Epigenetic Dysregulation of Trophoblastic Gene Expression in Gestational Trophoblastic Disease.

Szabolcsi Z, Demeter A, Kiraly P, Balogh A, Wilson M, King J Biomedicines. 2021; 9(12).

PMID: 34944751 PMC: 8698431. DOI: 10.3390/biomedicines9121935.


Expression of the Carbohydrate Lewis Antigen, Sialyl Lewis A, Sialyl Lewis X, Lewis X, and Lewis Y in the Placental Villi of Patients With Unexplained Miscarriages.

Ma Z, Yang H, Peng L, Kuhn C, Chelariu-Raicu A, Mahner S Front Immunol. 2021; 12:679424.

PMID: 34135905 PMC: 8202085. DOI: 10.3389/fimmu.2021.679424.


Understanding and management of gestational trophoblastic disease.

Ning F, Hou H, Morse A, Lash G F1000Res. 2019; 8.

PMID: 31001418 PMC: 6464061. DOI: 10.12688/f1000research.14953.1.


Gestational trophoblastic neoplasms (GTNs) do not display epithelial-to-mesenchymal transition (EMT) features.

Dubruc E, Allias F, Morel A, Golfier F, Puisieux A, Devouassoux-Shisheboran M Virchows Arch. 2019; 475(1):121-125.

PMID: 30847562 DOI: 10.1007/s00428-019-02551-7.


Hypermethylation and loss of retinoic acid receptor responder 1 expression in human choriocarcinoma.

Huebner H, Strick R, Wachter D, Kehl S, Strissel P, Schneider-Stock R J Exp Clin Cancer Res. 2017; 36(1):165.

PMID: 29169400 PMC: 5701501. DOI: 10.1186/s13046-017-0634-x.


References
1.
Chaddha V, Viero S, Huppertz B, Kingdom J . Developmental biology of the placenta and the origins of placental insufficiency. Semin Fetal Neonatal Med. 2005; 9(5):357-69. DOI: 10.1016/j.siny.2004.03.006. View

2.
Mullen C . Review: analogies between trophoblastic and malignant cells. Am J Reprod Immunol. 1998; 39(1):41-9. DOI: 10.1111/j.1600-0897.1998.tb00332.x. View

3.
Ishikawa N, Harada Y, Tokuyasu Y, Nagasaki M, Maruyama R . Re-evaluation of the histological criteria for complete hydatidiform mole: Comparison with the immunohistochemical diagnosis using p57KIP2 and CD34. Biomed Res. 2009; 30(3):141-7. DOI: 10.2220/biomedres.30.141. View

4.
Solter D, Knowles B . Monoclonal antibody defining a stage-specific mouse embryonic antigen (SSEA-1). Proc Natl Acad Sci U S A. 1978; 75(11):5565-9. PMC: 393007. DOI: 10.1073/pnas.75.11.5565. View

5.
Malassine A, Blaise S, Handschuh K, Lalucque H, Dupressoir A, Evain-Brion D . Expression of the fusogenic HERV-FRD Env glycoprotein (syncytin 2) in human placenta is restricted to villous cytotrophoblastic cells. Placenta. 2006; 28(2-3):185-91. DOI: 10.1016/j.placenta.2006.03.001. View